releases: https://harris.house.gov/media/press-releases/fda-set-make-decisions-based-diversity-statements-rather-science
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://harris.house.gov/media/press-releases/fda-set-make-decisions-based-diversity-statements-rather-science | FDA Set To Make Decisions Based On Diversity Statements Rather Than Science | 2024-01-12 | 2024 | 2024-01 | Republican | House | MD | Andy Harris | H001052 | harris.house.gov | harris | https://harris.house.gov/media/press-releases | scraper | Washington, D.C. – The FDA is set early this year to promote their Chief Scientist, Dr. Namandjé Bumpus, to the #2 position of “principal deputy commissioner” at the FDA. It has been discovered that while at Johns Hopkins, Dr. Bumpus gauged promotions on “diversity statements” in applications rather than on scientific merit. Statement From Dr. Harris: | 1 | 2026-03-30T01:40:41Z | 2026-04-06T23:46:48Z |